{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:49:25Z","timestamp":1791902965640,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1007\/s11916-002-0084-8","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T03:03:14Z","timestamp":1180839794000},"page":"408-413","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacotherapy of tension-type headaches"],"prefix":"10.1007","volume":"6","author":[{"given":"Mark J.","family":"Stillman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"Suppl 7","key":"84_CR1","first-page":"1","volume":"8","author":"Headache Classification Committee of the International Headache Society","year":"1988","unstructured":"Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988, 8(Suppl 7):1\u201396.","journal-title":"Cephalalgia"},{"key":"84_CR2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.279.5.381","volume":"279","author":"BS Schwartz","year":"1998","unstructured":"Schwartz BS, Stewart WS, Simon D, Lipton RB: Epidemiology of tension-type headache. JAMA 1998, 279:381\u2013383.","journal-title":"JAMA"},{"key":"84_CR3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1468-2982.1991.1105233.x","volume":"11","author":"HB Messinger","year":"1991","unstructured":"Messinger HB, Spierings ELH, Vincent AJP: Overlap of migraine and tension-type headache in the International Headache Society Classification. Cephalalgia 1991, 11:233\u2013237.","journal-title":"Cephalalgia"},{"key":"84_CR4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1468-2982.1996.1604217.x","volume":"16","author":"BK Rasmussen","year":"1996","unstructured":"Rasmussen BK: Migraine and tension-type headache are separate disorders. Cephalalgia 1996, 16:217\u2013223.","journal-title":"Cephalalgia"},{"key":"84_CR5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00019052-200006000-00009","volume":"13","author":"R Jensen","year":"2000","unstructured":"Jensen R, Olesen J: Tension-type headache: an update on mechanism and treatment. Curr Opin Neurol 2000, 13:285\u2013289. Authoritative article by two leaders in the field on theories pertaining to tension-type headaches, pathophysiologic correlation, and therapy.","journal-title":"Curr Opin Neurol"},{"key":"84_CR6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1526-4610.2000.00044.x","volume":"40","author":"JD Rollnik","year":"2000","unstructured":"Rollnik JD, Tanneberger O, Schubert M, et al.: Treatment of tension-type headache with botulinum toxin type A: a doubleblind, placebo-controlled study. Headache 2000, 40:300\u2013305.","journal-title":"Headache"},{"key":"84_CR7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3959(01)00292-5","volume":"91","author":"H Gobel","year":"2001","unstructured":"Gobel H: Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes. Pain 2001, 91:195\u2013199. Current review of the literature of therapeutic uses of botulinum toxin for primary and cervicogenic headaches.","journal-title":"Pain"},{"key":"84_CR8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N","volume":"47","author":"R Burstein","year":"2000","unstructured":"Burstein R, Yarnitsky D, Goor-Aryeh I, et al.: An association between migraine and cutaneous allodynia. Ann Neurol 2000, 47:614\u2013624.","journal-title":"Ann Neurol"},{"key":"84_CR9","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/brain\/123.8.1703","volume":"123","author":"R Burstein","year":"2000","unstructured":"Burstein R, Cutrer M, Yarnitsky D: The development of cutaneous allodynia during a migraine attack: clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000, 123:1703\u20131709.","journal-title":"Brain"},{"key":"84_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0733-8619(05)70302-9","volume":"15","author":"N Mathew","year":"1997","unstructured":"Mathew N: Transformed migraine, analgesic rebound, and other chronic daily headaches. Neurol Clin 1997, 15:167\u2013185.","journal-title":"Neurol Clin"},{"key":"84_CR11","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1526-4610.1990.hed3010634.x","volume":"30","author":"N Mathew","year":"1990","unstructured":"Mathew N, Kurman R, Perez F: Drug-induced refractory headache: clinical features and management. Headache 1990, 30:634\u2013638.","journal-title":"Headache"},{"key":"84_CR12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0304-3959(93)90131-8","volume":"52","author":"R Jensen","year":"1993","unstructured":"Jensen R, Rasmussen BK, Pedersen B, Olesen J: Muscle tenderness and pressure pain thresholds in headache: a population study. Pain 1993, 52:193\u2013199.","journal-title":"Pain"},{"key":"84_CR13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archneur.1996.00550040113021","volume":"53","author":"L Bendtsen","year":"1996","unstructured":"Bendtsen L, Jensen R, Olesen J: Decreased pain detection and tolerance thresholds in chronic tension-type headache. Arch Neurol 1996, 53:373\u2013376.","journal-title":"Arch Neurol"},{"key":"84_CR14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0304-3959(91)90198-7","volume":"47","author":"J Schoenen","year":"1991","unstructured":"Schoenen J, Bottin D, Hardy F, Gerard P: Cephalic and extracephalic pressure pain thresholds in chronic tension-type headache. Pain 1991, 47:145\u2013149.","journal-title":"Pain"},{"key":"84_CR15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0304-3959(89)90239-X","volume":"38","author":"M Langemark","year":"1989","unstructured":"Langemark M, Jensen K, Jensen TS, Olesen J: Pressure pain thresholds and thermal nociceptive thresholds in chronic tension-type headache. Pain 1989, 38:203\u2013210.","journal-title":"Pain"},{"key":"84_CR16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1468-2982.1996.1604223.x","volume":"16","author":"GE Tietjen","year":"1996","unstructured":"Tietjen GE: The primary headache disorder: apple sauce or fruit cocktail. Cephalalgia 1996, 16:223.","journal-title":"Cephalalgia"},{"key":"84_CR17","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/brain\/122.9.1611","volume":"122","author":"PJ Goadsby","year":"1999","unstructured":"Goadsby PJ: Chronic tension-type headache: where are we? Brain 1999, 122:1611\u20131612.","journal-title":"Brain"},{"key":"84_CR18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1526-4610.2000.00143.x","volume":"40","author":"RB Lipton","year":"2000","unstructured":"Lipton RB, Stewart WF, Cady RK: Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache 2000, 40:783\u2013791. An important study that supports the continuum theory of migraine and tension-type headache. It points out which group of patients with episodic tension-type headache will likely respond to the triptan class of drugs.","journal-title":"Headache"},{"key":"84_CR19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1468-2982.1996.1604220.x","volume":"16","author":"JA Leston","year":"1996","unstructured":"Leston JA: Migraine and tension-type headache are not separate disorders. Cephalalgia 1996, 16:220\u2013222.","journal-title":"Cephalalgia"},{"key":"84_CR20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3959(90)91052-K","volume":"40","author":"G DeBenedittis","year":"1990","unstructured":"DeBenedittis G, Lorenzetti A, Pieri A: The role of stressful life events in the onset of chronic primary headache. Pain 1990, 40:65\u201375.","journal-title":"Pain"},{"key":"84_CR21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1468-2982.1998.1807455.x","volume":"18","author":"V Guidetti","year":"1998","unstructured":"Guidetti V, Galli F, Fabrizi P: Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia 1998, 18:455\u2013462.","journal-title":"Cephalalgia"},{"key":"84_CR22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0002-9343(83)90526-0","volume":"74","author":"BH Peters","year":"1983","unstructured":"Peters BH, Fraim CJ, Masel BE: Comparison of 650 mg of aspirin and 1000 mg of acetaminophen with each other and with placebo in moderately severe headache. Am J Med 1983, 74:36\u201342.","journal-title":"Am J Med"},{"key":"84_CR23","first-page":"238","volume-title":"Wolff\u2019s Headache and Other Head Pain","author":"S Solomon","year":"2001","unstructured":"Solomon S, Newman LC: Episodic tension-type headaches. In Wolff\u2019s Headache and Other Head Pain, edn 7. Edited by Silberstein SD, Lipton RB, Dalessio DJ. New York: Oxford University Press; 2001:238\u2013246.","edition":"edn 7"},{"key":"84_CR24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1526-4610.1998.3808579.x","volume":"38","author":"DR Mehlish","year":"1998","unstructured":"Mehlish DR, Wearer M, Flading B: Ketoprofen, acetaminophen, and placebo in the treatment of tension headache. Headache 1998, 38:579\u2013589.","journal-title":"Headache"},{"key":"84_CR25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1468-2982.1998.1801038.x","volume":"18","author":"CGH Dahlof","year":"1998","unstructured":"Dahlof CGH, Jacobs LD: Ketoprofen, paracetamol, and placebo in the treatment of episodic tension-type headache. Cephalalgia 1998, 18:38\u201343.","journal-title":"Cephalalgia"},{"key":"84_CR26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1468-2982.1998.1801038.x","volume":"18","author":"TJ Steiner","year":"1998","unstructured":"Steiner TJ, Lange R: Ketoprofen (25 mg) in the symptomatic treatment of episodic tension-type headache: double-blind placebo-controlled comparison with acetaminophen (1000 mg). Cephalalgia 1998, 18:38\u201343.","journal-title":"Cephalalgia"},{"key":"84_CR27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/WNL.50.2.507","volume":"50","author":"RN Harden","year":"1998","unstructured":"Harden RN, Rogers D, Fink K, Gracely RH: Controlled trial of ketorolac in tension-type headache. Neurology 1998, 50:507\u2013509.","journal-title":"Neurology"},{"key":"84_CR28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1067\/mcp.2000.109353","volume":"68","author":"S Diamond","year":"2000","unstructured":"Diamond S, Balm TK, Freitag FG: Ibuprofen plus caffeine in the treatment of tension-type headache. Clin Pharmacol Ther 2000, 68:312\u2013319.","journal-title":"Clin Pharmacol Ther"},{"key":"84_CR29","first-page":"1","volume-title":"Conn\u2019s Current Therapy.","author":"M Stillman","year":"2000","unstructured":"Stillman M: Pain. In Conn\u2019s Current Therapy. Edited by Rakel RE. Philadelphia: W B Saunders; 2000:1\u20135."},{"key":"84_CR30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1526-4610.1998.3806453.x","volume":"38","author":"R Cerbo","year":"1998","unstructured":"Cerbo R, Barbanti P, Fabbrini G, et al.: Amitriptyline is effective in chronic but not episodic tension-type headache: pathogenetic implications. Headache 1998, 38:453\u2013457.","journal-title":"Headache"},{"key":"84_CR31","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(64)91866-5","volume":"1","author":"JW Lance","year":"1964","unstructured":"Lance JW, Curran DA: Treatment of chronic tension headache. Lancet 1964, 1:1236\u20131239.","journal-title":"Lancet"},{"key":"84_CR32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1526-4610.1971.hed1103110.x","volume":"10","author":"S Diamond","year":"1971","unstructured":"Diamond S, Baltes BJ: Chronic tension headache treated with amitriptyline: a double-blind study. Headache 1971, 10:110\u2013116.","journal-title":"Headache"},{"key":"84_CR33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1468-2982.1994.1402149.x","volume":"14","author":"V Pfaffenrath","year":"1994","unstructured":"Pfaffenrath V, Diener HC, Isler H: Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-center controlled study. Cephalalgia 1994, 14:149\u2013155.","journal-title":"Cephalalgia"},{"key":"84_CR34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1526-4610.1981.hed2103105.x","volume":"21","author":"NT Mathew","year":"1981","unstructured":"Mathew NT: Prophylaxis of migraine and mixed headache: a randomized, controlled trial. Headache 1981, 21:105\u2013109.","journal-title":"Headache"},{"key":"84_CR35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0002-9343(01)00762-8","volume":"111","author":"GE Tomkins","year":"2001","unstructured":"Tomkins GE, Jackson JL, O\u2019Malley PG, et al.: Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med 2001, 111:54\u201363. Using meta-analysis, this study reaffirms what has been clinically assumed for years.","journal-title":"Am J Med"},{"key":"84_CR36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jnnp.61.3.285","volume":"61","author":"L Bendtsen","year":"1996","unstructured":"Bendtsen L, Jensen R, Olesen J: A non-selective (amitriptyline), but not a selective (citalopram) serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996, 61:285\u2013290.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"84_CR37","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1468-2982.2000.00087.x","volume":"20","author":"L Bendtsen","year":"2000","unstructured":"Bendtsen L, Jensen R: Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headaches. Cephalalgia 2000, 20:603\u2013610. A revealing investigation of amitriptyline\u2019s effect on pericranial tenderness through its reduction of central sensitization.","journal-title":"Cephalalgia"},{"key":"84_CR38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1526-4610.1997.3707433.x","volume":"37","author":"GL Cohen","year":"1997","unstructured":"Cohen GL: Protriptyline, chronic tension-type headaches, and weight loss in women. Headache 1997, 37:433\u2013436.","journal-title":"Headache"},{"key":"84_CR39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1526-4610.2000.00089.x","volume":"40","author":"LC Adelman","year":"2000","unstructured":"Adelman LC, Adelman JU, Von Seggern R, Mannix LK: Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 2000, 40:572\u2013580.","journal-title":"Headache"},{"key":"84_CR40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1526-4610.2000.040008633.x","volume":"40","author":"K Murros","year":"2000","unstructured":"Murros K, Kataja M, Hedman C, et al.: Modified-release formulation of tizanidine in chronic tension-type headache. Headache 2000, 40:633\u2013637.","journal-title":"Headache"},{"key":"84_CR41","unstructured":"Ruoff GE: Another look at tizanidine: mechanism of action and wide spectrum of clinical usage [abstract]. Presented at the International Headache Society Meeting. New York: June 29\u2013July 2, 2001."},{"key":"84_CR42","unstructured":"Lake AE, Saper JR, Spierings EL, et al.: Chronic daily headache prophylaxis with tizanidine: a double-blind, multicenter outcome study [abstract]. Presented at the American Headache Society Meeting. Seattle: June 21\u2013June 23, 2002."},{"key":"84_CR43","first-page":"454","volume":"19","author":"JA Smuts","year":"1999","unstructured":"Smuts JA, Baker MK, Smuts HM, et al.: Botulinum toxin-type A as prophylactic treatment in chronic tension-type headache. Cephalalgia 1999, 19:454.","journal-title":"Cephalalgia"},{"key":"84_CR44","first-page":"455","volume":"19","author":"H Gobel","year":"1999","unstructured":"Gobel H, Lindner V, Krack P, et al.: Treatment of chronic tension-type headache with botulinum toxin. Cephalalgia 1999, 19:455.","journal-title":"Cephalalgia"},{"key":"84_CR45","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1526-4610.2000.00044.x","volume":"40","author":"JD Rollnik","year":"2000","unstructured":"Rollnik JD, Tanneberger O, Schubert M, et al.: Treatment of tension-type headache with botulinum toxin-type A: a doubleblind, placebo-controlled study. Headache 2000, 40:300\u2013305.","journal-title":"Headache"},{"key":"84_CR46","unstructured":"Mathew NT, Kailasam J, Meadors L: \u2019Disease modification\u2019 in chronic migraine with botulinum toxin-type A: long-term experience [abstract]. Presented at the American Headache Society Meeting. Seattle: June 21\u2013June 23, 2002."},{"key":"84_CR47","unstructured":"Eros EJ, Doric DW: The effects of botulinum toxin-type A on disability in episodic and chronic migraine [abstract]. Presented at the American Headache Society Meeting. Seattle: June 21\u2013June 23, 2002."},{"key":"84_CR48","unstructured":"Ondo WG, Derman HS: Botulinum toxin-type A for chronic daily headache: a 60-patient, randomized, placebo-controlled, parallel design study [abstract]. Presented at the American Headache Society Meeting. Seattle: June 21\u2013June 23, 2002."},{"key":"84_CR49","unstructured":"Edwards KR, Dreyer MD: Botulinum toxin-type A (Botox) for chronic daily headache [abstract]. Presented at the American Headache Society Meeting. Seattle: June 21\u2013June 23, 2002."},{"key":"84_CR50","unstructured":"Troost B: Botulinum toxin-type A (Botox, Allergan, Irvine, CA) therapy for intractable headaches [abstract]. Presented at the American Headache Society Meeting. Seattle: June 21\u2013June 23, 2002."},{"key":"84_CR51","unstructured":"Blumenfeld A: Decrease in headache medication use and cost after botulinum toxin-type A (Botox) treatment in a hightriptan use population [abstract]. Presented at the American Headache Society Meeting. Seattle: June 21\u2013June 23, 2002."},{"key":"84_CR52","unstructured":"Miller T: Retrospective cohort analysis of 48 chronic headache patients treated with botulinum toxin-type A (Botox) in a combination fixed injection site and follow-the-pain protocol [abstract]. Presented at the American Headache Society Meeting. Seattle: June 21\u2013June 23, 2002."},{"key":"84_CR53","unstructured":"Barrientos N, Chana P: Efficacy and safety of botulinum toxintype A (Botox) in the prophylactic treatment of migraine [abstract]. Presented at the American Headache Society Meeting. Seattle: June 21\u2013June 23, 2002."},{"key":"84_CR54","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0140-6736(98)01079-4","volume":"353","author":"M Ashina","year":"1999","unstructured":"Ashina M, Lassen LH, Bendtsen L, et al.: Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomized, crossover trial. Lancet 1999, 353:287\u2013289.","journal-title":"Lancet"},{"key":"84_CR55","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/brain\/122.9.1629","volume":"122","author":"M Ashina","year":"1999","unstructured":"Ashina M, Bendtsen L, Jensen R, et al.: Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tensiontype headache. Brain 1999, 122:1629\u20131635.","journal-title":"Brain"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-002-0084-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-002-0084-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-002-0084-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:34:07Z","timestamp":1559435647000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-002-0084-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["84"],"URL":"https:\/\/doi.org\/10.1007\/s11916-002-0084-8","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}